VCAM1 and atherosclerosis: Inhibition of ER stress with 4-PBA greatly suppressed the increased VCAM-1 expression induced by pro-atherogenic TGRL, but only moderately lowered TGRL’s anti-atherogenic activity, suggesting that therapeutics targeting ER stress may provide efficacious treatment of atherosclerosis.